Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

Cas9, scientists reconstitute live African swine fever virus from synthetic genomes, accelerating vaccine development for ...

CRISPR-Cas9 is effective at generating small mutations ... a gene-engineer at the University of Nebraska Medical Center in Omaha, who co-invented Easi-CRISPR in 2017. Everything came together ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

When the CRISPR Cas9 protein is added to a cell along with a piece of guide RNA, the Cas9 protein hooks up with the guide RNA and then moves along the strands of DNA until it finds and binds to a ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...